Shravani Mikkilineni MD
Oculo-Plastic & Orbital Reconstructive Surgery
Physician
Join to View Full Profile
29201 Telegraph RdSuite 324Southfield, MI 48034
Phone+1 248-357-5100
Dr. Mikkilineni is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Shravani Mikkilineni is an Oculoplastic and Orbital Reconstructive Surgeon based in Southfield, MI. She completed her medical degree at the University of Michigan, followed by ophthalmology residency at Henry Ford Health. She completed an Ophthalmic Plastic and Reconstructive Surgery fellowship at OHSU. Additionally, she holds an MBA from the University of Michigan Ross School of Business.
Education & Training
Oregon Health and Science UniversityOphthalmic Plastic and Reconstructive Surgery Fellowship, 2021 - 2023
Henry Ford Health/Henry Ford HospitalResidency, Ophthalmology, 2017 - 2021- University of Michigan Ross School of BusinessMBA, 2015 - 2017
University of Michigan Medical SchoolClass of 2016
Certifications & Licensure
MI State Medical License 2023 - 2026
OR State Medical License 2021 - 2025
American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 7 citationsCiliochoroidal effusion syndrome with central serous-like chorioretinopathy and secondary angle closure following exogenous testosterone use.Daniel Brill, Desiree C Albert, Taylor Fields, Shravani Mikkilineni, David A. Crandall
American Journal of Ophthalmology Case Reports. 2019-06-05 - 14 citationsVisual Field Mean Deviation at Diagnosis of Idiopathic Intracranial Hypertension Predicts Visual OutcomeShravani Mikkilineni, Jonathan D. Trobe, Wayne T. Cornblath, Lindsey B. De Lott
Journal of Neuro-Ophthalmology. 2019-06-01 - 13 citationsGeographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United StatesEmily W. Gower, Joshua D. Stein, Nakul Shekhawat, Shravani Mikkilineni, Taylor Blachley
American Journal of Ophthalmology. 2017-12-01
Press Mentions
Third Annual Research Scholar Honoree Program Draws Global InterestFebruary 1st, 2020
Ophthalmology Times® Announces Winners of 3rd Annual Research Scholar Honoree ProgramOctober 30th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
